Tomáš Bolek

489 total citations
55 papers, 307 citations indexed

About

Tomáš Bolek is a scholar working on Cardiology and Cardiovascular Medicine, Internal Medicine and Surgery. According to data from OpenAlex, Tomáš Bolek has authored 55 papers receiving a total of 307 indexed citations (citations by other indexed papers that have themselves been cited), including 40 papers in Cardiology and Cardiovascular Medicine, 21 papers in Internal Medicine and 13 papers in Surgery. Recurrent topics in Tomáš Bolek's work include Atrial Fibrillation Management and Outcomes (25 papers), Venous Thromboembolism Diagnosis and Management (21 papers) and Antiplatelet Therapy and Cardiovascular Diseases (16 papers). Tomáš Bolek is often cited by papers focused on Atrial Fibrillation Management and Outcomes (25 papers), Venous Thromboembolism Diagnosis and Management (21 papers) and Antiplatelet Therapy and Cardiovascular Diseases (16 papers). Tomáš Bolek collaborates with scholars based in Slovakia, United States and Czechia. Tomáš Bolek's co-authors include Matej Samoš, Marián Mokáň, Ján Staško, Peter Kubisz, Ingrid Škorňová, Péter Galajda, Lucia Stančiaková, František Kovář, Jela Ivanková and Martin Jozef Péč and has published in prestigious journals such as SHILAP Revista de lepidopterología, Medicine and Diabetes Research and Clinical Practice.

In The Last Decade

Tomáš Bolek

49 papers receiving 304 citations

Peers

Tomáš Bolek

CCM

SURGE

EPIDE

HEMAT

Matej Samoš Slovakia

František Kovář Slovakia

Lucia Stančiaková Slovakia

Ahmed Nagy United States

Sophie Galier France

Ashley Chen United States

Mattias Wieloch Sweden

Goran Koraćević Serbia

Juan Carlos Claro Chile

Marta Bellesini Italy

Matej Samoš Slovakia

Tomáš Bolek

263 ×1.4

CCM

145 ×1.3

81 ×1.4

SURGE

43 ×1.2

EPIDE

41 ×1.2

HEMAT

Citations per year, relative to Tomáš Bolek Tomáš Bolek (= 1×) peers Matej Samoš

Countries citing papers authored by Tomáš Bolek

Since Specialization

Citations

This map shows the geographic impact of Tomáš Bolek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tomáš Bolek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tomáš Bolek more than expected).

Fields of papers citing papers by Tomáš Bolek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tomáš Bolek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tomáš Bolek. The network helps show where Tomáš Bolek may publish in the future.

Co-authorship network of co-authors of Tomáš Bolek

This figure shows the co-authorship network connecting the top 25 collaborators of Tomáš Bolek. A scholar is included among the top collaborators of Tomáš Bolek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tomáš Bolek. Tomáš Bolek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Péč, Martin Jozef, Tomáš Bolek, Ingrid Škorňová, et al.. (2025). Endothelial Markers in Type 2 Diabetic Patients with Acute Decompensated Heart Failure: A Pilot Study. Metabolites. 15(2). 91–91. 1 indexed citations

Samoš, Matej, Mária Škereňová, Ingrid Škorňová, et al.. (2025). ABCB1 Gene Single-Nucleotide Variants and Haplotypes in Atrial Fibrillation Patients Experiencing Adverse Events on Direct Oral Anticoagulation: A Whole Gene Exome Sequencing Study. Journal of Cardiovascular Pharmacology. 86(1). 50–59.

Mitro, P, et al.. (2024). Application of Liquid Chromatography Coupled to Mass Spectrometry for Direct Estimation of the Total Levels of Adenosine and Its Catabolites in Human Blood. Pharmaceuticals. 17(3). 345–345. 1 indexed citations

Péč, Martin Jozef, et al.. (2024). A fast-growing myxoma of the left atrium. European Journal of Case Reports in Internal Medicine. 11(5). 4490–4490.

Péč, Martin Jozef, Tomáš Bolek, Juraj Sokol, et al.. (2024). Unilateral upper and lower limb ischemia mimics stroke: a case report. Journal of Medical Case Reports. 18(1). 66–66. 1 indexed citations

Péč, Martin Jozef, et al.. (2024). Left Ventricular and Atrial Deformation in Patients with Acute Decompensated Heart Failure: A Pilot Study. Diagnostics. 14(13). 1368–1368.

Škorňová, Ingrid, et al.. (2023). High On-Treatment Platelet Reactivity in Patients Undergoing Complex Percutaneous Coronary Interventions. Clinical and Applied Thrombosis/Hemostasis. 29. 2995380593–2995380593. 1 indexed citations

Mikušová, Veronika, Tomáš Bolek, Martin Jozef Péč, et al.. (2023). MiR-126 and miR-146a as markers of type 2 diabetes mellitus: a pilot study. Bratislavské lekárske listy/Bratislava medical journal. 124(7). 527–533. 8 indexed citations

Bolek, Tomáš, Štefan Sivák, Egon Kurča, et al.. (2023). A high‐throughput liquid chromatography‐tandem mass spectrometry method for simultaneous determination of direct oral anticoagulants in human plasma. Journal of Separation Science. 46(13). e2300084–e2300084. 6 indexed citations

10.

Péč, Martin Jozef, et al.. (2023). Obesity as a risk factor in atrial fibrillation and heart failure. Journal of Diabetes & Metabolic Disorders. 23(1). 125–134. 6 indexed citations

11.

Bolek, Tomáš, Matej Samoš, Lucia Stančiaková, et al.. (2023). COVID-19 and the Response to Antiplatelet Therapy. Journal of Clinical Medicine. 12(5). 2038–2038. 4 indexed citations

12.

Škorňová, Ingrid, Tomáš Bolek, Lucia Stančiaková, et al.. (2022). Plasma levels of direct oral anticoagulants in atrial fibrillation patients at the time of embolic stroke: a pilot prospective multicenter study. European Journal of Clinical Pharmacology. 78(4). 557–564. 16 indexed citations

13.

Bolek, Tomáš, et al.. (2019). Severe hypoglycemia due to insulin self-injection as a cause of acute ST elevation myocardial infarction. Journal of Diabetes & Metabolic Disorders. 18(2). 739–742. 2 indexed citations

14.

Samoš, Matej, Tomáš Bolek, Ingrid Škorňová, et al.. (2019). Direct Oral Anticoagulants: Novel Approach for the Treatment of Thrombosis in Pediatric Patients?. Pediatric Cardiology. 40(7). 1431–1438. 3 indexed citations

15.

Samoš, Matej, Jana Žolková, Lucia Stančiaková, et al.. (2018). On-treatment platelet reactivity in the era of new ADP receptor blockers: data from a real-world clinical practice. SHILAP Revista de lepidopterología. 18(2). 34–39. 1 indexed citations

16.

Samoš, Matej, Tomáš Bolek, Lucia Stančiaková, et al.. (2018). Anti-Xa activity in oral factor Xa inhibitor-treated patients with atrial fibrillation and a higher risk of bleeding. Blood Coagulation & Fibrinolysis. 29(4). 369–373. 10 indexed citations

17.

Samoš, Matej, Tomáš Bolek, Lucia Stančiaková, et al.. (2017). Does type 2 diabetes affect the on-treatment levels of direct oral anticoagulants in patients with atrial fibrillation?. Diabetes Research and Clinical Practice. 135. 172–177. 8 indexed citations

18.

Bolek, Tomáš, Matej Samoš, Lucia Stančiaková, et al.. (2017). The Impact of Proton Pump Inhibition on Dabigatran Levels in Patients With Atrial Fibrillation. American Journal of Therapeutics. 26(3). e308–e313. 27 indexed citations

19.

Samoš, Matej, František Kovář, Péter Galajda, et al.. (2016). The Impact of Type 2 Diabetes on the Efficacy of ADP Receptor Blockers in Patients with Acute ST Elevation Myocardial Infarction: A Pilot Prospective Study. Journal of Diabetes Research. 2016. 1–6. 1 indexed citations

20.

Samoš, Matej, František Kovář, Péter Galajda, et al.. (2014). Prasugrel loading dose in diabetic patients with acute STEMI - Always sufficiently effective? Observation in two cases and review of current knowledge. Cor et Vasa. 56(5). e388–e395. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact